ASCO25,GastricCancer – MashupMD

Mashup Score: 4

Imfinzi Combo Boosts Survival in Resectable Gastric and GEJ Cancer - 5 day(s) ago

Adding Imfinzi to fluorouracil-based chemo improved event-free survival and response rates in resectable gastric and gastroesophageal junction cancer.

Source: www.curetoday.com

Categories: General Medicine News, Nursing

Tweet Tweets with this article
- cure_today
  
  Imfinzi Combo Boosts Survival in Resectable Gastric and GEJ Cancer @YJanjigianMD @MSKCancerCenter @ASCO #ASCO25 #GastricCancer https://t.co/uigCKcNYhN

Mashup Score: 3

Trastuzumab Deruxtecan Improves Survival in HER2-Positive Gastric Cancer : Oncology Times - 6 day(s) ago

An abstract is unavailable.

Source: journals.lww.com

Categories: General Medicine News, Onc News and Journals

Tweet Tweets with this article
- OncologyTimes
  
  Results from the Phase III DESTINY-Gastric04 study presented at #ASCO25 showed that T-DXd led to an improvement in overall survival compared to the current standard of care for #GastricCancer. https://t.co/N2amH04T2n https://t.co/6Z6zfff7Xf